Denmark stands at a crossroads: a small, high-tech economy riding a pharmaceutical boom, yet increasingly aware of how dependent it has become on a few winners like Novo Nordisk. At the same time, long-run trade data suggest that export patterns are surprisingly sticky, changing only slowly even as governments talk about diversification and resilience.
In this episode, we unpack new insights from a 2025 report by the Embassy of Switzerland and an academic study from Aalborg University on export specialization across OECD countries. We explore how Denmark’s recent growth has been powered by its pharma sector, why looming labor shortages and overreliance on a single industry giant pose strategic risks, and what “path dependence” really means for a small open economy. We also look at the subtle global trend toward de-specialization, where countries gradually broaden their trade profiles instead of betting everything on a few sectors.
Finally, we zoom in on the evolving economic relationship between Denmark and Switzerland, especially in chemicals and machinery, and ask what a more diversified, resilient Danish economy could look like over the next decade. If you’re interested in how export structures, industrial policy, and international partnerships shape a nation’s future room for maneuver, this conversation is for you.
If you like what you hear, please consider supporting the podcast either on Apple Podcast or on Spotify: https://creators.spotify.com/pod/profile/iqulture/subscribe
Also follow my content on Patreon: https://www.patreon.com/cw/IQulture
or Medium: https://medium.com/bastian-friborg-consulting